PLEASANTON, Calif.--(EON: Enhanced Online News)--10x Genomics, Inc., a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced that Serge Saxonov, Ph.D., co-founder and chief executive officer will present corporate and product updates during the 35th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 9, 2017 at 9:30 a.m. PT.
“We are honored to have been selected to present at the J.P. Morgan Healthcare Conference for the third consecutive year”
“We are honored to have been selected to present at the J.P. Morgan Healthcare Conference for the third consecutive year,” said Dr. Saxonov. “2016 has been a pivotal year for the company with multiple product launches, key scientific publications and accelerated adoption in the marketplace. We look forward to sharing updates on milestone achievements from the past year as well as upcoming product development plans.”
About 10x Genomics
10x Genomics is changing the definition of sequencing by providing an innovative genomics platform that dramatically upgrades the capabilities of existing sequencing technologies. This is achieved through a combination of new microfluidic science, chemistry and bioinformatics. By implementing GemCode™ Technology within the Chromium™ System, researchers can now, for the first time, find new structural variants, haplotypes and other valuable genomic information with comprehensive workflows for Single Cell, Genome, Exome and de novo Assembly applications that incorporate their pre-existing sequencing technologies.